Meyahealth
HomeGeneticsGeneFMR1 gene
Back to Gene
FMR1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

FMR1 gene

The FMR1 gene provides instructions for making a protein called FMRP, which is essential for normal brain development and the regulation of synaptic plasticity.

Normal Function

The FMR1 gene provides instructions for making a protein called FMRP. This protein is present in many tissues, including the brain, testes, and ovaries. In the brain, it plays a role in the development of connections between nerve cells (synapses) and helps regulate synaptic plasticity, which is important for learning and memory.

Researchers believe that FMRP acts as a shuttle within cells by transporting messenger RNA (mRNA), the genetic blueprint for making proteins, from the nucleus to areas where proteins are assembled. It also helps control when these instructions are used to build proteins.

One region of the FMR1 gene contains a CGG trinucleotide repeat. In most people, this segment is repeated fewer than 10 to about 40 times. This segment is typically stabilized by an AGG sequence scattered among the CGG triplets.

Health Conditions Related to Genetic Changes

Fragile X-associated primary ovarian insufficiency (FXPOI)

A premutation (55 to 200 CGG repeats) increases a woman's risk of FXPOI. This condition can cause irregular menstrual cycles, infertility, early menopause, and elevated levels of follicle stimulating hormone (FSH). The premutation leads to the overproduction of abnormal FMR1 mRNA, which may bind to other proteins and impair their function. Additionally, some individuals with the premutation have lower than normal levels of FMRP.

Fragile X-associated tremor/ataxia syndrome (FXTAS)

Men and some women with an FMR1 gene premutation are at increased risk of FXTAS, a disorder characterized by progressive movement problems (ataxia), tremor, memory loss, peripheral neuropathy, and mental/behavioral changes. Abnormal FMR1 mRNA forms clumps (intranuclear inclusions) in brain and nerve cells, which may contribute to the death of nerve cells or prevent proteins from performing their normal functions.

Fragile X syndrome

Almost all cases of fragile X syndrome are caused by an expansion of the CGG repeat to more than 200 times. This makes the gene unstable, causing it to be turned off (silenced). The resulting loss of FMRP disrupts nervous system function, leading to severe learning problems, intellectual disability, and sometimes features of autism spectrum disorders.

Other disorders

The FMR1 premutation is associated with fragile X-associated neuropsychiatric disorders (FXAND). This includes learning disabilities, ADHD, autism spectrum disorder, depression, anxiety, obsessive-compulsive disorder, fatigue, chronic pain, and insomnia.

Genomic Location

The FMR1 gene is found on the X chromosome.

Frequently Asked Questions

Parents often notice speech delays, unusual hand movements (like hand flapping), or social anxiety in toddlers. In school-aged children, challenges with attention, hyperactivity, or learning difficulties, especially in reading and math, can be early clues. If these symptoms appear, a pediatrician may recommend a genetic test for the FMR1 CGG repeat count.
The most common test is a PCR-based assay that quantifies CGG repeats, sometimes supplemented by Southern blotting if the repeat number is very high. Prior to testing, avoid medications that may interfere with DNA extraction, and inform the lab if you have a known family history of fragile X. The test is usually done on a blood sample, and results are available in 2–4 weeks.
Women with premutations should undergo regular ovarian reserve testing (AMH, FSH) and consider fertility counseling early. For both men and women, regular neurological exams starting in the 30s can catch early tremor or ataxia. Maintaining a healthy diet, regular exercise, and avoiding neurotoxic medications (e.g., certain chemotherapeutics) may help reduce symptom severity. Early intervention with physical or occupational therapy can also improve quality of life.
repeat count of 55–200 is considered a premutation and raises the risk of fragile X–associated primary ovarian insufficiency (FXPOI) in women, with a 20–30% chance of early menopause. The same premutation range also increases the risk of fragile X–associated tremor/ataxia syndrome (FXTAS) in older adults, with risk rising to about 40–50% in men over 50. Full mutations (>200 repeats) are associated with full fragile X syndrome and typically do not cause FXPOI or FXTAS.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ